A novel null-allele, HLA-B*35:574N, containing a mutation in the start-codon.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
06 2023
Historique:
revised: 25 01 2023
received: 24 01 2023
accepted: 27 01 2023
medline: 17 5 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

HLA-B*35:574N contains a single nucleotide substitution at nucleotide position 2 (ATG to ACG).

Identifiants

pubmed: 36718102
doi: 10.1111/tan.14982
doi:

Substances chimiques

Codon, Initiator 0
HLA-B Antigens 0
Nucleotides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

676-677

Informations de copyright

© 2023 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. The IPD-IMGT/HLA database. Nucleic Acids Res. 2022;51:D1053-D1060. doi:10.1093/nar/gkac1011
Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455. doi:10.1111/j.1399-0039.2010.01466.x

Auteurs

Mirzokhid Rakhmanov (M)

Freiburg University Medical Center, Faculty of Medicine, Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Freiburg, Germany.

Martin Bernheiden (M)

Freiburg University Medical Center, Faculty of Medicine, Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Freiburg, Germany.

Murielle Verboom (M)

Hanover Medical School, Institute of Transfusion Medicine and Transplant Engineering, Hanover, Germany.

Maike Hofmann (M)

Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Florian Emmerich (F)

Freiburg University Medical Center, Faculty of Medicine, Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Freiburg, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH